Showing 1,657 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

EACS: Predictors of HCV Viral Load in HIV/HCV Coinfected Patients

Editor's pick
HIVandhepatitis.com
27 October 2011
Hepatitis B

IDSA: Hep B Vaccine Benefit Persists in HIV Patients (CME/CE)

Editor's pick
MedPage Today HIV/AIDS
26 October 2011
New & experimental hepatitis C treatment

Vertex study will evaluate 12-week treatment period for some hepatitis C patients

Editor's pick
Boston.com
24 October 2011
New & experimental hepatitis C treatment

Abbott says hepatitis C combo may be a blockbuster

Editor's pick
Reuters
21 October 2011
Hepatitis C symptoms & diagnosis

India: Integrate Hepatitis C testing with HIV: NGOs

Editor's pick
Yahoo News
21 October 2011
Hepatitis B

'PATH B', a comprehensive support program in Europe for patients with chronic hepatitis B launched

Editor's pick
Eurekalert Medicine & Health
21 October 2011
New & experimental hepatitis C treatment

Interim Phase IIb Data for Merck's VICTRELIS™ (boceprevir) in Patients Coinfected with Chronic Hepatitis C and HIV-1

Editor's pick
Market Watch (press release)
20 October 2011
Hepatitis C treatment

EACS: Antiretroviral Therapy Reduces Liver Fibrosis Progression in HIV/HCV Coinfected People

Editor's pick
HIVandhepatitis.com
20 October 2011
New & experimental hepatitis C treatment

Sector Snap: Hepatitis C drug developers rise

Editor's pick
Bloomberg Business Week
18 October 2011
Harm reduction

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

Editor's pick
Drug and Alcohol Findings
18 October 2011
New & experimental hepatitis C treatment

Roche buys Anadys for $230 million to boost hep C business

Editor's pick
PharmaTimes
18 October 2011
Adherence

Hepatitis C Medication Adherence Is an Important Challenge, Study Shows

Editor's pick
AIDSMeds
13 October 2011
Adherence

Copy of Hepatitis C Medication Adherence Is an Important Challenge, Study Shows

Editor's pick
Kaiser Daily Global Health Policy Report
13 October 2011
New & experimental hepatitis C treatment

Transgene Says 3 Patients in Hepatitis Trial Had Blood Disorders

Editor's pick
Bloomberg Business Week
12 October 2011
New & experimental hepatitis C treatment

Pharmasset again expands hepatitis C drug study

Editor's pick
Bloomberg BusinessWeek
11 October 2011
New & experimental hepatitis C treatment

Vertex's Hep C Drug Needs A Growth Injection

Editor's pick
The Street
11 October 2011
New & experimental HIV treatments

Boehringer signs away HIV rights to focus on hep C - InPharm

Editor's pick
InPharm
7 October 2011
New & experimental hepatitis C treatment

ICAAC: HCV Drug Telaprevir Shows No Problematic Interactions with Raltegravir

Editor's pick
HIVandhepatitis.com
6 October 2011
Pharmaceutical industry

Bristol-Myers Is Close To Completing A Groundbreaking Hepatitis C Treatment

Editor's pick
Business Insider
3 October 2011
New & experimental hepatitis C treatment

Vertex takes early rounds of hep C bout with Merck

Editor's pick
Reuters
3 October 2011
Hepatitis C symptoms & diagnosis

Hepatitis C in the U.S. May Be Underestimated by Over a Million

Editor's pick
AIDSMeds
30 September 2011
Hepatitis C treatment

Hepatitis C patients likely to falter in adherence to treatment regimen over time, Penn study shows

Editor's pick
Eurekalert Medicine & Health
29 September 2011
Hepatitis C treatment

Updated Hepatitis C Practice Guidelines Now Available from AASLD

Editor's pick
Market Watch (press release)
28 September 2011
New & experimental hepatitis C treatment

J&J's hep C drug Incivo approved in Europe

Editor's pick
InPharm
22 September 2011